An electronic tool for venous thromboembolism prevention in medical and surgical patients

Haematologica

Volumn 91, Issue 1, 2006, Pages 64-70

  Samama, Meyer Michel ^a   Dahl, Ola E ^b   Mismetti, Patrick ^c   Quinlan, Daniel J ^d   Rosencher, Nadia ^e   Cornelis, Marleen ^f   De Vries, Han ^g   Van Beusekom, Ineke ^g   Kahan, James P ^g  

^a HÔTEL DIEU   (France)

^b THROMBOSIS RESEARCH INSTITUTE   (United Kingdom)

^c SERVICE DE NEUROLOGIE   (France)

^d KING S COLLEGE HOSPITAL   (United Kingdom)

^e UNIVERSITÉ PARIS DESCARTES   (France)

^f EVIDIS   (France)

^g RAND CORPORATION   (United States)

Author keywords

Prophylaxis; RAND UCLA appropriateness method; Risk matrix; Venous thromboembolism

Indexed keywords

ACETYLSALICYLIC ACID; ANTIVITAMIN K; DALTEPARIN; ENOXAPARIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; NADROPARIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE CLASSIFICATION; FEMALE; HUMAN; MALE; PROPHYLAXIS; REGRESSION ANALYSIS; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; SURGICAL PATIENT; VENOUS THROMBOEMBOLISM;

ALGORITHMS; DECISION SUPPORT TECHNIQUES; DIAGNOSIS, COMPUTER-ASSISTED; HUMANS; PREMEDICATION; RISK ASSESSMENT; THROMBOEMBOLISM; VENOUS THROMBOSIS;

EID: 32544454684     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Geerts WH, Pineo GF, Heit JA, Bergqvist D, Lassen MR, Colwell CW, et al. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126Suppl:5338S-400.
2. Nicolaides AN. Prevention of venous thromboembolism. International Consensus Statement. Guidelines compiled in accordance with the scientific evidence. Int Angiol 2001;20:1-37.
3. Second Thromboembolic Risk Factors (THRiFT II) Consensus Group. Risk of and prophylaxis for venous thromboembolism in hospital patients. Phlebology 1998;13:87-97.
4. Arcelus JI, Candocia S, Traverso CI, Fabrega F, Caprini JA, Hasty JH. Venous thromboembolism prophylaxis and risk assessment in medical patients. Semin Thromb Hemost 1991;17 Suppl 3:313-8.
5. Haas S. Prophylaxie thromboembolique: Quand? Et pour combien de temps? Tribune Medicale 1998;16:4-5.
6. Motykie GD, Zebala LP, Caprini JA, Lee CE, Arcelus JI, Reyna JJ, et al. A guide to venous thromboembolism risk factor assessment. J Thromb Thrombolysis 2000;9:253-62.
7. Fagot JP, Flahault A, Kanfer A, Benoit G, Bellanger A, Conort O, et al. [Prevention of venous thromboembolism in a non-surgical medical ward. Proposed indications for low molecular weight heparin]. Presse Med 2000; 29:4-10.
8. Lutz L, Haas S, Hach-Wunderle V, Betzl G, Jarmatz H. Venous thromboembolism in internal medicine: risk assessment and pharmaceutical prophylaxis. Med Welt 2002;53:231-4.
9. Samama MM, Janvier G, Chapuis C. Conférence Nationale de Consensus: Prophylaxie des thromboses veineuses et embolies post- opératoires en chirurgie générale, orthopédique et Gynécologique. Concours Medical 1991;113:1333-7.
10. Caprini JA, Arcelus JI, Hasty JH, Tamhane AC, Fabrega F. Clinical assessment of venous thromboembolic risk in surgical patients. Semin Thromb Hemost 1991;17 Suppl 3:304-12.
11. Chapuis Y, Augereau B, Clergue F, Flam T, Horellou HM, Levardon M. Prophylaxie de thromboses veineuses postopératoires: recommendations de l'Assistance publique-Hôpitaux de Paris. Sang Thromb Vaiss 1995;7:119-20.
12. Samama MM. Applying risk assessment models in general surgery: effective risk stratification. Blood Coagul Fibrinolysis 1999;10 Suppl 2:579-584.
13. Ageno W, Squizzato A, Ambrosini F, Dentali F, Marchesi C, Mera V, et al. Thrombosis prophylaxis in medical patients: a retrospective review of clinical practice patterns. Haematologica 2002;87:746-50.
14. Ahmad HA, Geissler A, MacLellan DG. Deep venous thrombosis prophylaxis: are guidelines being followed? ANZ J Surg 2002;72:331-4.
15. Caprini JA, Glase C, Martchev D, Oyslender M, Arcelus JI, Maksimovic D. Thrombosis risk factor assessment in surgical patients: compliance with chest consensus guidelines. J Thromb Haemost 2003;1 Suppl 1:July 12-18 [abstract #125].
16. Stratton MA, Anderson FA, Bussey HI, Caprini J, Comerota, A, Haines ST, et al. Prevention of venous thromboembolism: adherence to the 1995 American College of Chest Physicians consensus guidelines for surgical patients. Arch Intern Med 2000; 160: 334-40.
17. Aujesky D, Guignard E, Pannatier A, Cornuz J. Pharmacological thromboembolic prophylaxis in a medical ward: room for improvement. J Gen Intern Med 2002;17:788-91.
18. Kucher N, Koo S, Quiroz R, Cooper JM, Paterno MD, Soukonnikov B, et al. Electronic alerts to prevent venous thromboembolism among hospitalized patients. N Engl J Med 2005;352: 969-77.
19. Brook RH, Chassin MR, Fink A, Solomon DH, Kosecoff J, Park RE. A method for the detailed assessment of the appropriateness of medical technologies. Int J Technol Assess Health Care 1986;2:53-63.
20. Fitch K, Bernstein SJ, Aguilar M, Burnand B, LaCalle JR, Lazaro P, et al. The RAND/UCLA Appropriateness User's Manual. Santa Monica: RAND, MR-1269-DG XII/RE; 2001.
21. Samama MM, Dahl OE, Quinlan DJ, Mismetti P, Rosencher N. Quantification of risk factors for venous thromboembolism: a preliminary study for the development of a risk assessment tool. Haematologica 2003;88: 1410-21.
22. Wietlisbach V, Vader JP, Porchet F, Costanza MC, Burnand B. Statistical approaches in the development of clinical practice guidelines from expert panels: the case of laminectomy in sciatica patients. Med Care 1999;37:785-97.
23. Kahan JP, Cornelis M, de Vries H, van Beusekom I, Wietlishbach V. Preventing venous thromboembolism: prophylactic options for patients at different risk levels. Leiden: RAND-EVIDIS, MR-1689. 2003.
24. Lazaro P, Fitch K, Martin Y. Standards for the appropriate use of percutaneous transluminal coronary angioplasty and aortocoronary surgery. Rev Esp Cardiol 1998;51:689-715.
25. Fitch K, Lazaro P, Aguilar MD, Kahan JP, van het Loo M, Bernstein SJ. European criteria for the appropriateness and necessity of coronary revascularization procedures. Eur J Cardiothorac Surg 2000;18:380-7.
26. Scaglione L, Piobbici M, Pagano E, Ballini L, Tamponi G, Ciccone G. Implementing guidelines for venous thromboembolism prophylaxis in a large Italian teaching hospital: lights and shadows. Haematologica 2006; 90:678-84.
27. Shekelle PG, Kahan JP, Bernstein SJ, Leape LL, Kamberg CJ, Park RE. The reproducibility of a method to identify the overuse and underuse of medical procedures. N Engl J Med 1998; 338: 1888-95.
28. Russell MW, Taylor DC, Cummins G, Huse DM. Use of managed care claims data in the risk assessment of venous thromboembolism in outpatients. Am J Manag Care 2002;8 1 Suppl:S3-S9.
29. Clagett GP, Anderson FA Jr, Geerts W, Heit JA, Knudson M, Lieberman JR, et al. Prevention of venous thromboembolism. Chest 1998;114 5 Suppl:531S-60S.
30. Jackson N. The validity of the venous thromboembolism risk factor assessment model as described by Motykie et al. Available from http://www.med. monash.edu.au/healthservices/cce [Access Date 25/06/03]. 2002.
31. Lindqvist PG, Kublikas M, Dahlback B. Individual risk assessment of thrombosis in pregnancy. Acta Obstet Gynecol Scand 2002;81:412-6.